Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Open Studies | "Staphylococcal Infections"
Show Display Options
Rank Status Study
21 Unknown  Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention:
22 Unknown  Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
Condition: Methicillin Resistant Staphylococcus Aureus
Intervention:
23 Unknown  Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
Conditions: Methicillin-resistant Staphylococcus Aureus;   Pneumonia, Ventilator-Associated
Intervention: Drug: Imipenem/cilastatin
24 Recruiting Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization
Condition: Methicillin-resistant Staphylococcus Aureus
Interventions: Drug: Rifampin;   Drug: Doxycycline;   Other: 2% mupirocin ointment;   Other: 4% chlorhexidine gluconate
25 Recruiting Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Vancomycin continuous infusion;   Drug: Vancomycin intermittent dosing interval
26 Unknown  Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
Condition: Methicillin-resistant Staphylococcus Aureus Infection
Intervention: Other: Preoperative MRSA screening
27 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
28 Recruiting Building an Optimal Hand Hygiene Bundle
Conditions: Hand Hygiene;   MRSA - Methicillin Resistant Staphylococcus Aureus Infection;   Compliance
Intervention: Other: Hand Hygiene Compliance Signs
29 Not yet recruiting Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention: Drug: Beta-Lactam
30 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Conditions: Methicillin-Resistant Staphylococcus Aureus;   ESBL
Intervention:
31 Not yet recruiting Detection of Staph Colonization in Pre-op Arthroplasty Patients
Condition: Surgical Site Infection
Intervention:
32 Recruiting A Phase 3 Telavancin Staph Aureus Bacteremia Trial
Condition: Bacteremia
Interventions: Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: Cefazolin
33 Recruiting PK of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
Condition: Systemic Infection
Intervention: Drug: Antibiotic
34 Recruiting Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
Condition: Pneumonia Due to Staphylococcus Aureus
Interventions: Drug: KBSA301;   Drug: Placebo
35 Recruiting The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
Condition: Impetigo
Interventions: Drug: papaya 1% extract ointment;   Drug: mupirocin 2% ointment
36 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
37 Unknown  Citriodiol® and Impetigo
Condition: Impetigo
Intervention: Drug: p-menthane-3,8-diol oil
38 Recruiting Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
39 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
40 Recruiting Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Condition: Impetigo
Interventions: Drug: Ozenoxacin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years